| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 11,000 | $306.18 | $3,367,983.80 | -4.1% | -3.9% | +85.5% | |
| Dec 5, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 7,700 | $374.37 | $2,882,649.00 | -17.3% | -16.9% | +30.7% | |
| Nov 21, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 7,700 | $367.36 | $2,828,672.00 | -17.3% | +3.7% | +29.3% | |
| Apr 4, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $232.37 | $1,394,248.25 | -3.0% | +33.0% | +25.0% | |
| Mar 21, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $236.45 | $1,418,726.00 | -3.7% | +30.4% | +32.1% | |
| Mar 7, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $237.38 | $1,424,309.07 | -5.0% | +15.3% | +31.7% | |
| Feb 15, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $215.31 | $1,291,884.86 | -4.9% | +27.1% | +72.7% | |
| Feb 1, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $215.01 | $1,290,083.29 | -3.7% | +18.1% | +62.6% | |
| Jan 18, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $218.72 | $1,312,322.33 | -3.1% | +7.4% | +63.8% | |
| Jan 4, 2024 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $227.97 | $1,367,798.18 | -5.0% | +0.5% | +54.9% |